Zhipu Raises ARR Guidance to $3 Billion; Northbound Funds Record Over HK$3.1 Billion in Single-Day Net Buying
nashnova research
Zhipu (02513) raised its year-end 2026 ARR guidance from $2.4 billion to $3 billion on September 16, the same day northbound funds net-bought HK$3.12 billion of the stock — exceeding total northbound net inflows for the entire market.
What does a $3 billion ARR target actually mean?
At its September 16 analyst briefing, Zhipu disclosed it closed a $5 billion combined equity-and-debt round on September 11 and raised its year-end 2026 ARR guidance from $2.4 billion to $3 billion — a roughly 25% increase.
As of mid-September, company-wide monthly ARR already stands at $1.8 billion, but reaching $3 billion still requires nearly 70% more run-rate within roughly three and a half months.
ARR — annualized recurring revenue, a figure that takes current subscription or contract income and projects it over a year — is a management-perspective guide, not the same as audited accounting revenue. Actual recognized revenue depends on execution and accounting standards.
Why did northbound funds pile in on the same day?
On September 16, Zhipu (02513) drew HK$3.12 billion in net northbound buying — the single largest individual stock that day.
This means → total northbound net buying for the entire market was only HK$2.1 billion. Zhipu alone exceeded the market total, meaning all other stocks combined were net-sold.
In plain terms = southbound capital was effectively making a single-name bet on Zhipu, with extreme concentration, timed exactly to the analyst briefing's new disclosures.
How did Zhipu break its compute bottleneck?
After GLM-5.5 launched in February 2026, model demand surged nearly 10× from the start of the year. The flagship Coding Plan was forced into rationed sales — only 500 slots per day.
Between February and March, the company's "all in infra" push lifted compute utilization roughly 2.3×. After closing a $4 billion refinancing in July, it began scaling capacity.
Coding Plan returned to fully open sales in late July to early August; post-reopening sales jumped more than 15×. This means → the earlier rationing was a supply problem, not a demand one — once the bottleneck loosened, pent-up demand converted instantly.
Where does the $5 billion go?
Per the briefing, the $5 billion round translates to roughly RMB 30 billion in compute spending, enough to procure close to 100,000 accelerator cards.
The split: 40% for training and R&D, 60% for inference. In plain terms = six out of every ten dollars go straight to the revenue-generating layer — handling customer requests and running model outputs.
Management said that after the round closes, compute supply is no longer the binding constraint on near-term revenue growth.
What is the status of cloud-vendor revenue sharing and CoWork orders?
Zhipu has signed revenue-sharing agreements with multiple leading Chinese and overseas cloud providers to host GLM open-source models as managed APIs. Related revenue is expected to begin recognition from October 2026.
Cloud platforms running MaaS businesses with revenues above $10 billion must obtain security review and commercial authorization to use Zhipu's most advanced models. Partner names, per-platform revenue, and sharing ratios have not been disclosed.
Within one month of GLM-5.3's release, enterprise orders in the "to work" vertical exceeded RMB 1 billion; over 100 cybersecurity firms have integrated GLM models into their products and workflows.
What are the key milestones to watch next?
Whether cloud-vendor sharing revenue begins recognition on schedule from October is the first hurdle for new Q4 income.
Whether Coding and other products can sustain volume growth now that the compute bottleneck is eased will determine if monthly ARR can climb from $1.8 billion toward the $3 billion target.
On the capital-markets side, Zhipu completed its A-share IPO coaching acceptance in June and is currently in the pre-filing stage. The company has committed to no further equity financing to new investors after September 30 until its STAR Market listing.
市场有风险，内容仅供研究参考，不构成投资建议。